Can a set of tests tell you that you do not have cancer? No test can. What screening can do, for a small number of cancers, is find disease or pre-cancerous change early enough that treatment works better. For those cancers the benefit has been shown in large populations over many years. For most others, screening healthy people has not been shown to help, and sometimes it harms.
This guide separates the tests with strong evidence from the ones that depend on your risk and the ones that mainstream guidelines advise against. Recommended ages vary slightly between countries, so the ranges here are typical. Your own doctor should adjust them for family history and previous results.
Key points
- Cervical, bowel and breast screening have the strongest evidence of benefit for people at average risk.
- Lung screening with low-dose CT helps heavy smokers and recent ex-smokers, not the general population.
- PSA testing for prostate cancer is a shared decision because it can lead to treatment of cancers that would never have caused harm.
- Tumour markers, whole-body scans and thyroid ultrasound are not recommended for screening healthy people.
- Every screening test produces false alarms and some overdiagnosis. Knowing this in advance makes results easier to handle.
What makes a screening test worth having
A useful screening test must find a cancer that is common enough, at a stage when earlier treatment changes the outcome, with an acceptable rate of false alarms. Finding more cancers is not the same as saving lives. Some cancers grow so slowly that they would never have caused symptoms, and finding them only creates patients.
This is why good screening is a programme and not a single test. It has a defined age range, a repeat interval, quality control and a clear pathway for abnormal results. A one-off scan in a package has none of these protections.
Tests with strong evidence
Three programmes are supported by essentially every major guideline body. Cervical screening prevents cancer by finding and treating pre-cancerous cells. Bowel screening both finds early cancers and, with colonoscopy, removes polyps before they turn malignant. Mammography lowers deaths from breast cancer in the screened age groups, with a smaller effect than many people assume.
- Cervical: HPV test, cytology or both, typically from 25 to 65, every three to five years depending on the method. HPV vaccination does not remove the need for screening.
- Bowel: Stool test for hidden blood every one to two years, or colonoscopy about every ten years if normal, typically from 45 or 50 to 75.
- Breast: Mammography every one to two years, starting at 40 or 50 depending on the guideline, usually to around 74.
- Lung: Yearly low-dose CT for people of roughly 50 to 80 with a heavy smoking history who still smoke or stopped within about 15 years.
Tests that are a personal decision
PSA testing can find prostate cancer early, and in men of about 50 to 70 it modestly lowers the chance of dying from the disease. The price is a substantial rate of false alarms, biopsies, and treatment of slow cancers, with possible effects on continence and erections. Modern pathways using MRI before biopsy and active surveillance for low-risk disease have reduced this harm but not removed it. Discuss it, then decide.
Skin examination is sensible for people with fair skin, many moles, heavy sun exposure or a family history of melanoma, although it has not been proven as a population programme. Mammography between 40 and 49, and screening beyond 75, are similar grey areas where your values and health matter as much as the statistics.
Tests that are not recommended for healthy people
Blood tumour markers are the most common example. CEA, CA 19-9, CA 125, CA 15-3 and AFP rise with smoking, inflammation, benign cysts, liver conditions and menstruation. They can also be normal in a person with cancer. Trials of CA 125 with ultrasound for ovarian cancer did not reduce deaths and led to unnecessary operations. These tests are for monitoring a known cancer.
Whole-body MRI, CT or PET-CT in people without symptoms produce many incidental findings that need further scans or biopsies, and they have no proven benefit. Thyroid ultrasound screening has led to large rises in diagnosed thyroid cancer in some countries without any fall in deaths. Newer multi-cancer blood tests are promising but are still being evaluated and are not yet part of any mainstream guideline.
- Tumour marker panels in people without cancer
- Whole-body MRI, CT or PET-CT for reassurance
- Thyroid ultrasound without a lump or symptoms
- Ovarian screening with CA 125 and ultrasound at average risk
- Pancreatic screening at average risk
When your risk is higher than average
Family history changes the picture. A parent, brother, sister or child with bowel cancer, especially before 60, usually means starting colonoscopy earlier, often at 40 or ten years before their age at diagnosis. Several relatives with breast, ovarian, prostate or pancreatic cancer may point to an inherited gene change such as BRCA1 or BRCA2, and genetic counselling is the right first step.
Other groups need tailored surveillance: people with chronic hepatitis B or cirrhosis are offered liver ultrasound every six months, those with long-standing ulcerative colitis need regular colonoscopy, and people who had chest radiotherapy when young need early breast screening. These are medical surveillance plans, not package extras.
Understanding false alarms and overdiagnosis
Over ten years of regular mammograms, a large share of women will be recalled at least once for something that turns out to be harmless. Stool tests send many people to colonoscopy who have no cancer. This is how screening works, not a sign that something went wrong. A recall means more information is needed, and most recalls end with reassurance.
Overdiagnosis is harder to see. It means finding a real cancer that would never have troubled you. Nobody can tell which individual cancer that is, so it is usually treated. It is most relevant to prostate, thyroid and some breast findings. It is a good reason to avoid tests that lack evidence of benefit.
Doing screening tests during a trip abroad
Mammography, colonoscopy, cervical tests and low-dose CT can all be done to a high standard in accredited hospitals, often within a day or two. Colonoscopy needs bowel preparation the day before and sedation on the day, so plan a quiet evening and no flight until the next day at the earliest.
Think ahead about what happens if something is found. A polyp can be removed during the same colonoscopy, but a suspicious breast finding needs biopsy, pathology and a treatment plan that takes weeks. Take home the full images and pathology slides or blocks reference, and register the results with your doctor at home so your next screening date is not lost.
When to get medical help
Screening is only for people without symptoms. A breast lump, nipple discharge with blood, bleeding after menopause or between periods, blood in stool or urine, a persistent cough or hoarseness beyond three weeks, difficulty swallowing, unexplained weight loss or a mole that changes shape or colour all need diagnostic assessment by a doctor soon, even if a recent screening test was normal.
This guide is general information and does not replace advice from the doctor treating you. If you would like a specialist to look at your own case, send your reports and photographs: a Clinic-Y coordinator replies within 24 hours, and the case review is free.
Frequently Asked Questions
If my screening test is normal, am I clear?
A normal result lowers your chance of having that cancer now, but no test is perfect and cancers can develop between screens. Keep to the repeat schedule and report new symptoms whenever they appear, whatever the last result said.
Do I still need cervical screening after the HPV vaccine?
Yes. The vaccine prevents most but not all cancer-causing HPV types, and many adults were vaccinated after they had already been exposed. Screening intervals may become longer for vaccinated generations in future, but today the recommendation is to continue.
Is a colonoscopy better than a stool test?
Colonoscopy is more sensitive and can remove polyps at once, but it needs bowel preparation, sedation and carries a small risk of bleeding or perforation. Stool testing is simple and safe but must be repeated regularly, and a positive result still leads to colonoscopy. Both reduce bowel cancer deaths when done consistently.
Does dense breast tissue change anything?
Dense tissue makes mammograms harder to read and slightly raises breast cancer risk. Some doctors add ultrasound or MRI, particularly when other risk factors are present. Extra imaging finds more cancers and also more false alarms, so it is worth an individual discussion.